meta
|
evidence
oncology
Living systematic review and meta-analysis
malignant mesothelioma (mMS) - 1st line (L1)
1
<span style="margin-left: 0em;">chemotherapy</span>
<span style="margin-left: 1em;">platinum-based chemotherapy</span>
<span style="margin-left: 2em;">platinum derivate</span>
<span style="margin-left: 3em;">platinum association</span>
<span style="margin-left: 4em;">pemetrexed plus platin <i class='fa fa-circle' style='color: royalblue; font-size: 10px;'></i></span>
<span style="margin-left: 0em;">immune chekpoint inhibitors</span>
<span style="margin-left: 1em;">Immune checkpoint association</span>
<span style="margin-left: 2em;">nivolumab plus ipilimumab <i class='fa fa-circle' style='color: royalblue; font-size: 10px;'></i></span>
Select endpoint...
deaths (OS) (1)
progression or deaths (PFS) (1)
objective responses (ORR) (1)
DCR (1)
DOR (1)
TRAE leading to discontinuation (grade 3-4) (1)
TRAE leading to death (grade 5) (1)
TRAE leading to discontinuation (any grade) (1)
STRAE (any grade) (1)
Pruritus TRAE (grade 3-4) (1)
Rash TRAE (grade 3-4) (1)
Diarrhoea TRAE (grade 3-4) (1)
Colitis TRAE (grade 3-4) (1)
Increased ALT TRAE (grade 3-4) (1)
Increase AST TRAE (grade 3-4) (1)
Hepatitis TRAE (grade 3-4) (1)
Hypothyroidism TRAE (grade 3-4) (1)
Fatigue TRAE (grade 3-4) (1)
Nausea TRAE (grade 3-4) (1)
Arthralgia TRAE (grade 3-4) (1)
Anaemia TRAE (grade 3-4) (1)
Maculopapular rash TRAE (grade 3-4) (1)
Decreased appetite TRAE (grade 3-4) (1)
Asthenia TRAE (grade 3-4) (1)
Dyspnoea TRAE (grade 3-4) (1)
Pyrexia TRAE (grade 3-4) (1)
Pneumonitis TRAE (grade 3-4) (1)
Thrombocytopenia TRAE (grade 3-4) (1)
Neutropenia TRAE (grade 3-4) (1)
Vomiting TRAE (grade 3-4) (1)
Constipation TRAE (grade 3-4) (1)
Abdominal pain TRAE (grade 3-4) (1)
Increased lipase level TRAE (grade 3-4) (1)
Adrenal insufficiency TRAE (grade 3-4) (1)
Hypersensitivity TRAE (grade 3-4) (1)
Myositis TRAE (grade 3-4) (1)
Myocarditis TRAE (grade 3-4) (1)
Mucosal inflammation TRAE (grade 3-4) (1)
Stomatitis TRAE (grade 3-4) (1)
Acute kidney injury TRAE (grade 3-4) (1)
Infusion-related reactions TRAE (grade 3-4) (1)
Febrile neutropenia TRAE (grade 3-4) (1)
Pancytopenia TRAE (grade 3-4) (1)
Sepsis TRAE (grade 3-4) (1)
Pneumonia TRAE (grade 3-4) (1)
Arthritis TRAE (grade 3-4) (1)
Dermatitis acneiform TRAE (grade 3-4) (1)
study list
mapping
overview
meta-analysis
forest plot
NMA
excluded
insufficient data
Evidence network for deaths (OS)
1
CheckMate 743, 2021
pemetrexed plus platin
nivolumab plus ipilimumab
direct evidence
network meta-analysis
comet plot
result box
odds ratio
A
B
0.5
1.5
1.0
odds ratio for A vs. B
and half 95% CI
T
vs.
C
pemetrexed plus platin
nivolumab plus ipilimumab
pemetrexed plus platin
---
NA
nivolumab plus ipilimumab
NA
---
pathologies: 223 - treatments: 416,864
result logic
×
Study list
